Impurity reference standards
Lapatinib impurities & reference standards
Characterised Lapatinib impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
19reference materials
COAHPLC · NMR · MS on request
5-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)furan-2-carboxylic Acid
- CAS
- 1152131-73-1
- Formula
- C26H17ClFN3O4
- MW
- 489.9 g/mol
VQ-043205
![5-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furancarboxaldehyde chemical structure](/media/structures/XQPZOUAAXRXPAM-UHFFFAOYSA-N.svg)
5-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furancarboxaldehyde
- CAS
- 231278-84-5
- Formula
- C26H17ClFN3O3
- MW
- 473.9 g/mol
VQ-022924
N-(2-Cyano-4-iodophenyl)-N,N-dimethylformamidine
- CAS
- 903597-10-4
- Formula
- C10H10IN3
- MW
- 299.11 g/mol
VQ-039188
N-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-((((5-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)furan-2-yl)methyl)(2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine
- CAS
- 2172855-57-9
- Formula
- C55H43Cl2F2N7O6S
- MW
- 1038.9 g/mol
VQ-031447
![N-{3-Chloro-4-[(3-fluorobenzyl) oxy] phenyl}- 6-iodoquinazolin-4-amine chemical structure](/media/structures/UHFPFDMMKYQMLC-UHFFFAOYSA-N.svg)
N-{3-Chloro-4-[(3-fluorobenzyl) oxy] phenyl}- 6-iodoquinazolin-4-amine
- CAS
- 231278-20-9
- Formula
- C21H14ClFIN3O
- MW
- 505.7 g/mol
VQ-031446
![N-De[2-(methylsulfonyl)ethyl] Lapatinib chemical structure](/media/structures/NQHFMDSFFGTFSK-UHFFFAOYSA-N.svg)
FAQs — Lapatinib impurities
Which Lapatinib impurities do you supply?
We list 19 Lapatinib-related reference materials, including process impurities, degradation products and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Lapatinib impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Lapatinib impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Lapatinib impurity standards
We reply within one business day with price, pack options, lead time and documentation.